The thyroid gland-running the show behind the scenes – 2nd part
Authors:
Z. Límanová
Authors‘ workplace:
Univerzita Karlova v Praze, 1. lékařská fakulta, III. interní klinika VFN
Published in:
Čas. Lék. čes. 2009; 148: 124-128
Category:
Review Article
Overview
This paper follows on the previous article and describes the consequences of thyroid dysfunction in other medical branches. When treating celiac disease gastroenterologists should look for coincidentile hypothyreosis, which may also be associated with atrophic gastritis. Treatment by proton pump blockers may influence resorbtion of levothroxin. Heart disease problems in patients with thyreopathy is well known, yet further diagnostic methods may probably reveal even more nuanced heart complications in subclinical cases. The development of autoimmune disease is influenced by treatment with interferon, which is used in other medical branches. In female patients with breast cancer, antithyroid antibodies are found more frequently, and also subclinical dysfunctions are discovered more often than in the control group. Co-operation between gynecologists and endocrinologists may yield significant results, since a min, 4% of pregnant women are unaware of their thyroid malfunction. The malfunction may have negative impact on fetus psychomotoric development. Active search for thyroid gland dysfunction, existence of antibodies is in selected diseases fully warranted.
Key words:
thyroid, thyroid antibodies, celiacia, breast carcinoma, pregnancy.
Sources
1. Larizza D, Calcaterra V, Martinetti M, et al. Helicobacter pylori infection and autoimmune thyroid disease in young patients: the disadvantage of carrying the human leukocyte antigen-DRB1*0301 allele. J Clin Endocrinol Metab 2006; 91: 176–181.
2. Šterzl I, Hrdá P, Matucha P, et al. Helicobacter pylori, anti-thyroid peroxidase, anti-thyroglobulin and anti-gastric parietal cells antibodies in Czech population. Physiol Res 2008; 57 (Suppl 1): 135–141.
3. Centanni M, Marignani M, Gargano L, et al. Atrophy body gastritis in patients with autoimmune thyroid disease: an underdiagnosed association. Arch Intern Med 1999; 159: 1726–1730.
4. Hala El-Zimaity. Gastritis and gastric atrophy. Curr Opin Gastroenterol 2008; 24: 682–686.
5. Segni M, Borreli O, Pucarelli I, et al. Early manifestations of gastric autoimmunity in patients with juvenile autoimmune thyroid diseases. J Clin Endocrinol Metab 2004; 89: 4944–4948.
6. Centanni M, Gargano L, Canettie G, et al. Thyroxine in goiter, Helicobacter pylori infection and chronic gastritis. N Engl J Med 2006; 354: 1774–1795.
7. Lahner E, Centanni M, Agnello G, et al. Occurrence and risk factors for autoimmune thyroid disease in patients with atrophic body gastritis. Am J Med 2008; 121: 136–141.
8. Carta MG, Hardoy MC, Boi MF, et al. Association between panic disorder, major depressive disorder and celiac disease: a possible role of thyroid autoimmunity. J Psychosom Res 2002; 53: 789–793.
9. Jiskra J, Límanová Z, Vaníčková Z, et al. IgA and IgC antigliadin, IgA anti-tissue trans glutaminase and antiendomysial antibodies in patients with autoimmune thyroid disease and their relationship to thyroidal replacement therapy. Physiol Res 2003; 52: 79–88.
10. Iurio R, Mercuri V, Barbarulo F, et al. Prevalence of celiac disease in patients with autoimmune thyroiditis. Minerva Endocrinol 2007; 12: 239–243.
11. Meloni GF, Tomasi PA, Bertoncelli A, et al. Prevalence of silent celiac disease in patients with autoimmune thyroiditis from Northern Sardinia. J Endocrinol Invest 2001; 24: 298–302.
12. Elfstrom P, Montgomery SM, Kampe O, et al. Risk of thyroid disease in individuals with celiac disease. J Clin Endocrinol Metab 2008; 10: 3915–3921.
13. Tarantino G, Gagliardi G, Conc P. Do thyroid abnormalities detected in patients treated for HCV–related chronic hepatitis persist? Int J Immunopathol Pharmacol 2008; 21: 467–469.
14. Markovic NS, Djurica S, Brajovic M. Delated cardiomyopathy associated with autoimmune disease of thyroid gland. Srp Arh Celok Lek 2005; 10 (Suppl 1): 46–51.
15. Mayer O. Jr, Šimon J, Filipovský J, et al. Hypothyroidism in coronary heart disease and its relation to selected risk factors. Vasc Health Risk Manag 2006; 2: 499–506.
16. Mayer O Jr, Šimon J, Hrbková J, et al. Epidemilogical study of hypothyroidism as cardiovascular risk in population Čas Lék čes 2005; 144: 459–464.
17. Di Bello V, Monzani F, Giorgi D, et al. Ultrasonic myocardial textural analysis in subclinical hypothyroidism. J Am Soc Echocardiogr 2000; 13: 832–840.
18. Cappola A, Fried LP, Arnold LP, et al. Thyroid status, cardiovascular risk, and mortality in older adults. JAMA 2006; 289: 1033–1041.
19. Rodondi N, Aujesky D, Vittingoff E, et al. Subclinical hypothyroidism and the risk of coronary heart disease. Am J Med 2006; 119: 541–545.
20. Biondi B, Cooper DS. The clinical significance of subclinical thyroid dysfunction. Endocr Rev 2008; 29: 76–131.
21. Iervasie G, Molinaro S, Landi P, et al. An association between hypo – and hyperthyroidism and mortality. Archives of Internal Med 2007; 167: 1526–1532.
22. Mayer O. Jr, Čech J, Rosolova H, et al. Association between free thyroxine concentration and degree of heart failure in patients with chronic heart insuffitiency. Čas Lék čes 2005; 144: 742–746.
23. Melgren G, Bleskestad ICH, Aanderud S, et al. Thyrotoxicosis and paraparesis in a young woman: case report and review of the literature. Thyroid 2002; 1: 77–80.
24. Edwards LJ, Constantinescu CS. A prospective study of conditions associated with multiple sclerosis in a cohort of 658 consecutive outpatients attending a multiple sclerosis clinic. Mult Scler 2004; 10: 575–581.
25. THE CAMM S223 Trial Investigators: Altezumab vs. Interferon Beta1– in early multiple sclerosis. New Engl J Med 2008; 359: 1786–1802.
26. Cross JM, Girkin CA, Owsley C, et al. The association between thyroid problems and glaucoma. Br J Ophtalmol 2008; 92: 1503–1505.
27. D’Arbonneau F, Ansart S, Le Berre R, et al. Thyroid dysfunction in primary Sjogren’s syndrom: a long followup study. Arthritis Rheum 2003; 15: 804–809.
28. Valdivieso S, Kripper FCh, Ivelic JA, et al. High prevalence of thyroid dysfunction among psychiatric inpatients. Rev Med Chil 2006; 5: 623–628.
29. Payer J, Lysý L, Bagi L, et al. Hashimoto’s encephalopathy – a rare and unusual syndrome. Vnitř Lek 2007; 3: 300–306.
30. Vernino S, Geschwind M, Boeve, V. Autoimmune encephalopaties. Neurologist 2007; 5, 13: 140–147.
31. Mocellin R, Walterfang M, Velakoulis D. Hashimotos encephalopaty: epidemiology, pathogenesis and management. CNS Drugs 2007; 21: 799–811.
32. Astl J, Veselý D, Jablonický P. Pendredův syndrom, poznámky k problematice vrozené autosomálně recesivní percepční nedoslýchavosti spojené se strumou. Otorinolaryng a Foniat 2004; 53: 55–59.
33. Banghova K, Al Taji E, Cinek O, et al. Pendred syndrome among patients with congenital hypothyroidism detected by neonatal screening: identification of two novel PDS/SLC26A4 mutations. Eur J Pediatr 2008; 167: 777–783.
34. Coyle B, Coffey E, Armour JA, et al. Pendred syndrome (goiter and sensorineural hearing loss) maps to chromosome 7 in the region containing the nonsyndromic deafness gene DFNB4. Nat Genet 1996; 12: 421–423.
35. Bianchi G, Marchesini G, Zoli M, et al. Thyroid involvment in chronic inflammatory rheumological disorders. Clin Rheumatol 1993; 12: 479–484.
36. Innocencio RM, Romaldini JH, Ward, LS. Thyroid autoantibodies in autoimmune diseases. Medicina (B. Aires) 2004; 64: 227–230.
37. Metzger ML, Hudson MM, Somes GW, et al. White race as a risk for hypothyroidism after treatment for pediatric Hodgkinęs lymphoma. J Clin Oncol 2006; 24: 1516–1521.
38. Brignardello E, Corrais A, Isolato G, et al. Ultrasound screening for thyroid carcinoma in childhood cancer survivors: a case series. J Clin Endocrinol Metab 2008; 93: 4840–4843.
39. Sanders JE, Hoffmeister PA, Woolfrey AE, et al. Thyroid function following hematopoietic cell transplantation in children: 30 years experience. Blood 2009; 113: 306–308.
40. Steegman JL, Requena MJ, Martin-Regueira P, et al. High incidence of autoimmune alterations in myeloid leukemia patients treated with interferon-alfa. Am J Hematol 2003; 72: 170–176.
41. Gogas H, Ioannovich J, Dafni U, et al. Prognostic significance of autoimmunity during treatment of melanoma with interferon. N Engl J Med 2006; 354: 709–718.
42. Desai J, Yassal J, Marqusee E, et al. Hypothyroidism after sunitinib therapy for patients with gastrointestinal stromal tumors. Ann Int Med 2006; 145: 660–664.
43. Stein EM, Rivera C. Transient thyroiditis after treatment with lenalidomide in a patients with metastatic renal cell carcinoma. Thyroid 2007; 17: 681–683.
44. List A, Kurtin S, Roe, DJ, et al. Efficacy of Lenalidomid in myelodysplastic syndromes. New Engl J Med 2005; 352: 549–558.
45. Límanová Z, Barkmanová J, Friedmanová Z. Thyroid gland function in women with breast carcinoma. Vnitř Lék 1996; 42: 605–609.
46. Smyth PP, Shering SG, Kilbane MT, et al. Serum thyroid peroxiase autoantibodies, thyroid volume, and outcome in brest carcinoma. J Clin Endocrinol Metab 1998; 83: 2711–2716.
47. Jiskra J, Barkmanová J, Límanová Z, et al. Thyroid autoimmunity occurs more frequently in women with breast cancer compared to women with colorectal cancer and controls but it has no impact on relapse–free and overall survival. Oncology Reports 2007; 18: 1603–1611.
48. Spitzweg C, Morris JC. The sodium iodide symporter: its pathophysiological and therapeutic implications. Clin Endocrinol (Oxf) 2002; 57: 559–574.
49. Giustarini E, Pinchera A, Fierabracci P, et al. Thyroid autoimmunity in patients with malignant and benign breast diseases before surgery. Eur J Endocrinol 2006; 154: 645–649.
50. Petrich T, Helmeke HJ, Meyer GJ, et al. Establishment of radioactive astatine and iodine uptake in cancer cell lines expresing the human sodium/iodide symporter. Eur J Nucl Med Mol Imaging 2002; 29: 842–854.
51. Poppe K,Velkeniers B, Glinoer D. The role of thyroid autoimmunity in fertility and pregnancy. Nat Clin Pract Endocrinol Metab 2008; 4: 394–405.
52. Límanová Z, Potluková E. Význam preventivního vyšetření funkce štítné žlázy v graviditě. Prakt Gyn 2007; 11: 120–124.
53. Abalovich M, Nobuyuki A, Barbour L, et al. Management of thyroid dysfunction during pregnancy and postpartum: an endocrine society clinical practice guidline. J Clin Endocrin Metab 2007; 92 (Suppl 8), S1–S47.
54. Springer D, Horáček J, Hauerová, D, et al. Porucha štítné žlázy v těhotenství. Čes Gynek 2007; 72: 375–381.
Labels
Addictology Allergology and clinical immunology Angiology Audiology Clinical biochemistry Dermatology & STDs Paediatric gastroenterology Paediatric surgery Paediatric cardiology Paediatric neurology Paediatric ENT Paediatric psychiatry Paediatric rheumatology Diabetology Pharmacy Vascular surgery Pain managementArticle was published in
Journal of Czech Physicians
Most read in this issue
- Alveolar echinococcosis – a new emerging disease?
- Fatty acids – 2. Clinical and physiological significance
- The thyroid gland-running the show behind the scenes – 2nd part
- Perspectives of surgical treatment of vitiligo